Carlos Fernández de Larrea, MD, PhD, is a clinical hematologist at the Department of Hematology (Amyloidosis and Myeloma Unit) at Hospital Clínic de Barcelona, a junior researcher leader group at IDIBAPS, and an associate professor of medicine in Universitat de Barcelona.
During his career, he has been specially focused on multiple myeloma and AL amyloidosis, directing his research to the mechanisms of progression in monoclonal gammopathies. The work of his group in identifying innovative treatment options related to the patient’s immune system and the tumor micro-environment, with the goal of achieving the long-term remission of multiple myeloma, has been published in several international peer-reviewed papers.
Dr. Fernández de Larrea is the President of GEMMAC (Grup per a l’estudi del mieloma i la amiloïdosi de Catalunya) and was recently a Visitor Investigator at Memorial Sloan Kettering Center in New York.